A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.
Clinical trial NCT03628079 · TERMINATED
Trial details
- NCT number
- NCT03628079
- Sponsor
- Repos Pharma
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2019-01-16
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.